BioElectronics Files Form 15 With Securities and Exchange Commission

  • October 31st, 2012
  • News
  • 0 Comments
  • mcrowner

FREDERICK, MD–(Marketwire – Apr 19, 2011) – BioElectronics Corp. (PINKSHEETS: BIEL), the maker of disposable drug-free anti-inflammatory devices, today announced that it has filed a Form 15 with the SEC terminating the registration of the Company’s Common Stock under Section 12(g) of the Securities Exchange Act of 1934. As a result of this filing, the […]